The Algernon Value Proposition
-
Advancing new drug treatments for billion dollar global disease markets.
-
Advancing 3 lead compounds that either out performed or matched the gold standard of care treatment or one the leading drugs under development, in repeated animal in vivo studies. See our Pipeline
-
In the planning stages for 3 separate phase II clinical trials.
-
Highly capital efficient business model.
-
Experienced management team.